+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?



Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?



Medicina Clinica 142(8): 358-359




(PDF emailed within 0-6 h: $19.90)

Accession: 055181040

Download citation: RISBibTeXText

PMID: 24602748

DOI: 10.1016/j.medcli.2014.01.003


Related references

Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. Diabetes and Metabolism Journal 38(1): 32-34, 2014

Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?. Canadian Medical Association Journal 171(8): 857-857, 2004

Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiology Clinics 29(1): 47-70, 2011

Optimization of vitamin D status as an alternative strategy for primary prevention of cardiovascular events in type 2 diabetes mellitus. Journal of the American Geriatrics Society 58(4): 806-807, 2010

Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention. Israel Medical Association Journal 20(8): 480-485, 2018

Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus. Clinical Cardiology 35(12): 722-729, 2013

Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy 64(15): 1603-1610, 2007

Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong. American Journal of Cardiovascular Drugs 8(3): 199-205, 2008

PS41Characteristics Associated with Statin Prescribing for Primary Prevention of Cardiovascular Disease Among People with Diabetes. Journal of Epidemiology & Community Health 66(Suppl 1): A54.1-A54, 2012

Rosiglitazone reduces novel biomarkers of cardiovascular disease in subjects with type 2 diabetes mellitus already on statin therapy. Journal of the American College of Cardiology 43(5 Supplement A): 504A, March 3, 2004

Multifactorial lifestyle interventions in the primary and secondary prevention of cardiovascular disease and type 2 diabetes mellitus--a systematic review of randomized controlled trials. Annals of Behavioral Medicine 40(1): 49-64, 2011

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. American Journal of Cardiology 99(12a): 4i-20i, 2007

Primary cardiovascular prevention with statins in type 2 diabetes mellitus. Medicina Clinica 144(9): 431-432, 2016

Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention. Diabetes, Obesity and Metabolism 9(6): 792-798, 2007

Time- and Dose-Dependent Association of Statin Use With Risk of Clinically Relevant New-Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study. Journal of the American Heart Association 8(8): E011320, 2019